SCM
DRNA

Soleus Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Soleus Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,700
Closed -$235K – 64
2019
Q4 		$235K Buy
+10,700
New +$235K 0.23% 47